| Total subjects (n = 548) | Non-MetSyn | MetSyn | P value | |||||
---|---|---|---|---|---|---|---|---|---|
P1P1 (n = 35) | P1P2 (n = 107) | P2P2 (n = 128) | P1P1 (n = 26) | P1P2 (n = 134) | P2P2 (n = 118) | Among 6 groups | Non-MetSyn versus MetSyn | ||
Metabolic syndrome risk factors | |||||||||
Waist (cm) | 88.57 ± 9.23 | 82.23 ± 10.33a | 85.10 ± 8.25b | 83.80 ± 8.85ab,* | 93.15 ± 7.09c | 92.74 ± 7.73c | 92.99 ± 6.95c | <0.001 | <0.001 |
SBP (mmHg) | 129.28 ± 15.03 | 122.00 ± 9.35a | 123.09 ± 13.94a | 121.79 ± 12.49a | 138.08 ± 13.78b | 136.69 ± 14.49b | 134.81 ± 13.38b | <0.001 | <0.001 |
DBP (mmHg) | 81.83 ± 11.28 | 76.89 ± 9.34a | 77.75 ± 10.38a | 76.75 ± 9.54a | 89.69 ± 10.47c | 86.54 ± 10.75b | 85.45 ± 10.64b,* | <0.001 | <0.001 |
Fasting glucose (mmol/L) | 5.92 ± 1.45 | 5.19 ± 0.62a | 5.35 ± 0.76a | 5.50 ± 1.52a | 5.99 ± 0.80b | 6.39 ± 1.52c | 6.54 ± 1.61c | <0.001 | <0.001 |
Triglycerides (mmol/L) | 1.87 ± 1.14 | 1.08 ± 0.52a | 1.30 ± 0.70a | 1.30 ± 0.73a,* | 2.65 ± 1.18c | 2.29 ± 1.14b | 2.57 ± 1.24c,* | <0.001 | <0.001 |
HDL cholesterol (mmol/L) | 1.26 ± 0.33 | 1.51 ± 0.38d | 1.40 ± 0.33c | 1.37 ± 0.34c,* | 1.20 ± 0.32b | 1.13 ± 0.23ab | 1.09 ± 0.24a,** | <0.001 | <0.001 |
Anthropometric, lipid-related variables | |||||||||
BMI (kg/m2) | 25.43 ± 3.21 | 23.19 ± 2.95a | 24.33 ± 2.99b | 24.25 ± 3.07b,* | 26.56 ± 2.96c | 26.70 ± 2.85c | 26.68 ± 2.87c | <0.001 | <0.001 |
Total cholesterol (mmol/L) | 4.99 ± 0.93 | 4.97 ± 1.03a | 5.03 ± 0.97ab | 4.93 ± 0.91a | 5.26 ± 0.77b | 5.02 ± 1.00ab | 4.91 ± 0.82a,* | 0.139 | 0.693 |
LDL cholesterol (mmol/L) | 2.90 ± 0.86 | 3.08 ± 0.71c | 3.04 ± 0.88bc | 2.99 ± 0.77bc | 2.93 ± 0.73bc | 2.83 ± 0.91ab | 2.70 ± 0.88a | <0.001 | <0.001 |
Insulin resistance-related variables and lipoprotein lipase mass | |||||||||
Insulin (ulU/mL) | 5.17 ± 4.09 (n = 536) | 3.58 ± 2.58a (n = 34) | 4.53 ± 3.26a (n = 106) | 4.32 ± 3.67a (n = 122) | 5.80 ± 3.23b (n = 26) | 6.03 ± 4.56b (n = 131) | 5.99 ± 4.74b (n = 117) | <0.001 | <0.001 |
HOMA-IR | 1.40 ± 1.37 | 0.83 ± 0.58a | 1.09 ± 0.82a | 1.05 ± 0.90a | 1.53 ± 0.85b | 1.76 ± 1.85b | 1.79 ± 1.58b | <0.001 | <0.001 |
Lipoprotein lipase mass (ng/mL) | 39.64 ± 18.05 (n = 369) | 56.50 ± 18.42d (n = 25) | 45.21 ± 17.54c (n = 70) | 38.24 ± 15.92b,*** (n = 85) | 38.31 ± 13.22b (n = 16) | 38.70 ± 17.25b (n = 95) | 32.18 ± 17.68a,** (n = 78) | <0.001 | <0.001 |
Nutrient intake (n = 269) | |||||||||
Energy (kcal) | 1,829.30 ± 684.38 (n = 269) | 1,750.80 ± 600.99 (n = 18) | 1,824.12 ± 816.75 (n = 51) | 1,720.54 ± 703.90 (n = 59) | 1,814.82 ± 630.87 (n = 11) | 1,883.20 ± 655.05 (n = 71) | 1,904.33 ± 598.94 (n = 59) | 0.330 | 0.043 |
Energy-adjusted niacin (mg) | 16.89 ± 4.98 | 14.94 ± 3.95a | 17.33 ± 5.43b | 16.67 ± 3.72ab,* | 18.12 ± 3.76b | 17.21 ± 5.17b | 16.70 ± 5.78ab | 0.125 | 0.370 |
Frequency of life style (n = 500) | |||||||||
Physical activity | |||||||||
 Yes | 326 (66.0%) | 20 (6.1%) | 62 (19.0) | 76 (23.3%) | 15 (4.6%) | 82 (25.2%) | 71 (21.8%) | 0.928 | 0.486 |
 No | 168 (34.0%) | 10 (6.0%) | 36 (21.4%) | 36 (21.4%) | 9 (5.4%) | 42 (25.0%) | 35 (20.8%) | ||
Smoking habits | |||||||||
 Non-smoker | 241 (48.2%) | 21 (8.7%) | 52 (21.6%) | 72 (29.9%)* | 9 (3.7%) | 58 (24.1%) | 29 (12.0%)*** | <0.001 | <0.001 |
 Ex-smoker | 139 (27.8%) | 4 (2.9%) | 24 (17.3%) | 25 (18.0%) | 5 (3.6%) | 35 (25.2%) | 46 (33.1%) | ||
 Smoker | 120 (24.0%) | 7 (5.8%) | 22 (18.3%) | 16 (13.3%) | 11 (9.2%) | 33 (27.5%) | 31 (25.8%) | ||
Alcohol consumption | |||||||||
 Non-drinker | 164 (32.8%) | 16 (9.8%) | 34 (20.7%) | 41 (25.0%) | 5 (3.0%) | 42 (25.6%) | 26 (15.9%)* | <0.001 | 0.001 |
 Ex-drinker | 31 (6.2%) | 1 (3.2%) | 6 (19.4%) | 3 (9.7%) | 0 (0.0%) | 11 (35.5%) | 10 (32.3%) | ||
 Drinker | 305 (61.0%) | 15 (4.9%) | 58 (19.0%) | 69 (22.6%) | 20 (6.6%) | 73 (23.9%) | 70 (23.0%) |